Reuters logo
BRIEF-NanoCarrier decides to terminate clinical trial of NC-6004
December 21, 2016 / 9:12 AM / 9 months ago

BRIEF-NanoCarrier decides to terminate clinical trial of NC-6004

Dec 21 (Reuters) - NanoCarrier Co Ltd :

* Says it decides to terminate the first phase of clinical trial for NC-6004

Source text in Japanese: goo.gl/2zh3dq

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below